Ciuti R - Search Results

1

Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.

Ognibene A, Ciuti R, Tozzi P, Messeri G. Ognibene A, et al. Among authors: ciuti r. Prenat Diagn. 1999 Nov;19(11):1058-60. Prenat Diagn. 1999. PMID: 10589060

2

Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.

Bergesio F, Monzani G, Ciuti R, Cirami C, Martinelli F, Salvadori M, Tosi PL. Bergesio F, et al. Among authors: ciuti r. Nephron. 2001 Feb;87(2):127-33. doi: 10.1159/000045900. Nephron. 2001. PMID: 11244306

3

Lipids and apolipoproteins change during the progression of chronic renal failure.

Bergesio F, Monzani G, Ciuti R, Serruto A, Benucci A, Frizzi V, Salvadori M. Bergesio F, et al. Among authors: ciuti r. Clin Nephrol. 1992 Nov;38(5):264-70. Clin Nephrol. 1992. PMID: 1451339

4

Lipoprotein abnormalities in chronic renal failure and dialysis patients.

Monzani G, Bergesio F, Ciuti R, Rosati A, Frizzi V, Serruto A, Vitali D, Benucci A, Tosi PL, Bandini S, Salvadori M. Monzani G, et al. Among authors: ciuti r. Blood Purif. 1996;14(3):262-72. doi: 10.1159/000170270. Blood Purif. 1996. PMID: 8738541

5

Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.

Monzani G, Bergesio F, Ciuti R, Ciciani AM, Martinelli F, Rosati A, Salvadori M. Monzani G, et al. Among authors: ciuti r. J Nephrol. 1997 Jan-Feb;10(1):41-5. J Nephrol. 1997. PMID: 9241624 Clinical Trial.

6

Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.

Bergesio F, Monzani G, Guasparini A, Ciuti R, Gallucci M, Cristofano C, Castrignano E, Cupisti A, Barsotti G, Marcucci R, Abbate R, Bandini S, Gallo M, Tosi PL, Salvadori M. Bergesio F, et al. Among authors: ciuti r. Clin Nephrol. 2005 Aug;64(2):103-12. doi: 10.5414/cnp64103. Clin Nephrol. 2005. PMID: 16114786

7

Are lipid abnormalities reliable cardiovascular risk factors in dialysis patients?

Bergesio F, Ciuti R, Salvadori M, Galli GA, Monzani G, Bertoni E, Salerno A, Frizzi V. Bergesio F, et al. Among authors: ciuti r. Int J Artif Organs. 1989 Nov;12(11):677-82. Int J Artif Organs. 1989. PMID: 2599665

8

Neoral dose monitoring with cyclosporine 2-hour postdose levels (C(2)) in different renal transplant patient age groups.

Rosati A, Bertoni E, Zanazzi M, Di Maria L, Ciuti R, Piperno R, Moscarelli L, Biagini M, Salvadori M. Rosati A, et al. Among authors: ciuti r. Transplant Proc. 2001 Nov-Dec;33(7-8):3106-7. doi: 10.1016/s0041-1345(01)02324-7. Transplant Proc. 2001. PMID: 11750335 No abstract available.

9

[Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment].

Bergesio F, Ciuti R, Innocenti D, Galli GA, Frizzi V. Bergesio F, et al. Among authors: ciuti r. G Clin Med. 1985 Nov-Dec;66(11-12):433-40. G Clin Med. 1985. PMID: 3835087 Italian. No abstract available.

10

[Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].

Bergesio F, Ciuti R, Manfredi M, Frizzi V, Zerboni R. Bergesio F, et al. Among authors: ciuti r. Minerva Nefrol. 1983 Jul-Sep;30(3):165-73. Minerva Nefrol. 1983. PMID: 6646491 Italian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters